Regenerative stem cell therapy for bronchiectasis
Part of Lungs & breathing clinical trials.
This trial tests whether transplanting your own lung stem cells can repair damaged airways caused by bronchiectasis. It is for people with moderate to severe breathing impairment and aims to improve lung function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 80 years old.
- You have been diagnosed with bronchiectasis.
- Your lung function tests show FEV1 is at least 35% of normal and DLCO is between 30% and 80% of normal.
- You are not pregnant, breastfeeding, or planning pregnancy in the next year.
- You do not have active cancer or a history of cancer.
- You do not have HIV, hepatitis B, hepatitis C, or syphilis infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a patient's own lung stem cells can be used to repair damaged lungs in people with interstitial lung disease. It is an early-stage trial to see if the treatment is safe and may help improve breathing.
This trial tests whether transplanting a patient's own lung stem cells can improve lung function in people with chronic obstructive pulmonary disease (COPD). It aims to see if this treatment is safe and helps repair damaged lung tissue.
This early trial tests if airway basal stem cells can help children with a serious lung condition called bronchiolitis obliterans. It aims to improve lung function and reduce the need for oxygen or breathing support.
This trial is testing a new type of cell therapy called REGEND007 for people with COPD. It looks at whether the treatment can help improve how far you can walk and your overall breathing.
This trial tests whether a single dose of stem cells given through a bronchoscope is safe for people whose lungs are failing after a transplant. It may help those with a condition called bronchiolitis obliterans syndrome (BOS), a type of chronic rejection that makes it harder to breathe.
This trial aims to grow lung stem cells and create mini-lungs (organoids) from the tissue of people with COPD. It may help researchers understand the disease better and develop new treatments.
Hear when a new Bronchiectasis Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.